SCHEMBL631923

SCHEMBL631923

Nc1cccc(-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.63
TSHR P16473 1/20 0.61
MAPK1 P28482 1/20 0.61
MAOA P21397 1/20 0.59
AGXT P21549 1/20 0.56
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
CYP17A1 P05093 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP19A1 P11511 1/20 0.50
CYP11B1 P15538 1/20 0.50
CYP11B2 P19099 1/20 0.50
DHODH Q02127 1/20 0.49
PTGS1 P23219 2/20 0.49
MAOB P27338 1/20 0.47
MAP4K4 O95819 2/20 0.47
TAAR1 Q96RJ0 1/20 0.47
KDM1A O60341 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27978294 0.96 KIF11 (0.59) KIF11TSHRMAPK1MAOAAGXT
SCHEMBL3789224 0.86 TSHR (0.76) KIF11TSHRMAPK1MAOAPTGS1
SCHEMBL26821713 0.85 KIF11 (0.73) KIF11TSHRAGXTDHODHMAOB
SCHEMBL30364070 0.85 MAOA (0.55) KIF11TSHRMAPK1MAOAAGXT
SCHEMBL25012498 0.84 TSHR (0.61) KIF11TSHRMAPK1MAOACA12
SCHEMBL10049636 0.84 TSHR (0.52) KIF11TSHRMAPK1MAOAAGXT
SCHEMBL31131353 0.82 MAOA (0.84) MAOACA12CA1CA2CA9
SCHEMBL29561461 0.82 MAOA (0.84) MAOACA12CA1CA2CA9
SCHEMBL311194 0.82 MAOA (0.84) MAOACA12CA1CA2CA9
SCHEMBL29394565 0.82 MAOA (0.84) MAOACA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12465588-B2 Indole carboxamide derivative and pharmaceutical composition containing same KUKJE PHARMA CO., LTD. (KR) 2025-11-11 US disclosed
CN-114302874-B Indole carboxamide derivatives and pharmaceutical compositions containing the same 国际药品株式会社 2025-02-25 CN disclosed
WO-2023156485-A1 TRIARYLALKYL BORATE SALTS AS COINITIATORS IN NIR PHOTOPOLYMER COMPOSITIONS COVESTRO DEUTSCHLAND AG (DE) 2023-08-24 WO disclosed
US-20230000821-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME KUKJE PHARMA CO., LTD. (KR) 2023-01-05 US disclosed
CN-113667164-B Polyimide multilayer structure and method for producing same 达胜科技股份有限公司 2022-12-23 CN disclosed
EP-4023638-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Kukje Pharma Co., Ltd. (KR) 2022-07-06 EP disclosed
CN-114302874-A Indole carboxamide derivatives and pharmaceutical compositions comprising same 国际药品株式会社 2022-04-08 CN disclosed
CN-113667164-A Polyimide multilayer structure and method for producing same 达胜科技股份有限公司 2021-11-19 CN disclosed
WO-2021040393-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 국제약품 주식회사 2021-03-04 WO disclosed
US-8586617-B2 Aminomethyl-4-imidazoles HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-1694281-A2 BIPHENYL COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2006-08-30 EP disclosed
US-20060183754-A1 Amide bridged piphenyl or biazaphenyl derivatives F. HOFFMANN-LA ROCHE AG (CH) 2006-08-17 US disclosed
WO-2006052499-A1 CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS ARRAY BIOPHARMA, INC. (US) 2006-05-18 WO disclosed
US-20060094644-A1 Capreomycin derivatives and their use as antibacterials ARRAY BIOPHARMA, INC. 2006-05-04 US disclosed
US-20060074111-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2006-04-06 US disclosed
WO-2006020358-A2 NOVEL BIPHENYL COMPOUNDS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2006-02-23 WO disclosed
WO-2005062847-A2 COMPOUNDS, COMPOSITIONS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2005-07-14 WO disclosed
WO-2005060692-A2 BIPHENYL COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2005-07-07 WO disclosed
EP-1513795-A2 PROPIONIC ACID DERIVATIVES AND THEIR USE AS HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2005-03-16 EP disclosed
WO-2004000762-A2 PROPIONIC ACID DERIVATIVES AND THEIR USE AS HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12465588-B2 Indole carboxamide derivative and pharmaceutical composition containing same PTGES, PTGES2, PTGS1 KIF11 3898/4885TSHR 3725/4885MAPK1 843/4885
US-20230000821-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME PTGES, PTGES2, PTGS1 KIF11 3898/4885TSHR 3725/4885MAPK1 843/4885
US-20060183754-A1 Amide bridged piphenyl or biazaphenyl derivatives PPARD, PPARA, PPARG KIF11 2818/4885TSHR 226/4885MAPK1 2160/4885
US-20060074111-A1 Chemical compounds HDAC3, HAT1, H1-3 KIF11 2312/4885TSHR 849/4885MAPK1 848/4885
US-20060094644-A1 Capreomycin derivatives and their use as antibacterials SPOUT1, CAPRIN1, FBL KIF11 3866/4885TSHR 3260/4885MAPK1 2526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.